December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

58.94 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
88 89 Next >
News headline image
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
 
Via Benzinga
News headline image
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
From Bristol Myers Squibb
Via Business Wire
News headline image
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Bristol-Myers Squibb? ↗
 
Via Benzinga
News headline image
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields ↗
Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time. 
Via InvestorPlace
News headline image
U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
From Bristol Myers Squibb
Via Business Wire
News headline image
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
From Bristol Myers Squibb
Via Business Wire
News headline image
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
News headline image
Why Bristol Myers Squibb Stock Is Sinking Today ↗
Investors didn't like the biopharmaceutical company's updated guidance. 
Via The Motley Fool
News headline image
Uncover the Potential: 3 Discounted Stocks Ready for a Comeback ↗
Investors should considered these discounted stocks to buy for generous returns due to current undervaluation and strong fundamentals. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire? ↗
Keep your goals in check when considering an extreme contrarian trade with Bristol Myers Squibb stock. 
Via The Motley Fool
News headline image
If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today ↗
The answer isn't great, but there's still reason to like Bristol Myers Squibb. 
Via The Motley Fool
News headline image
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases 
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
3 Top ETFs to Buy for Passive Income in May ↗
These ETFs provide investors with above-average income streams. 
Via The Motley Fool
Topics ETFs
News headline image
Last Week's Worst-Performing Stocks: Are These 10 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024) ↗
10 worst performing large-cap stocks last week: LKQ, MSCI, TXT, EDU, BMY, MANH, RS, META, LUV, NUE. Analysts cut price targets for many. 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights ↗
 
Via Benzinga
News headline image
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
News headline image
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
From Bristol Myers Squibb
Via Business Wire
News headline image
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points ↗
 
Via Benzinga
Topics Stocks
News headline image
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results ↗
 
Via Benzinga
News headline image
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions ↗
Discover Bristol Myers Squibb's impressive first-quarter performance, with revenues exceeding expectations driven by key products like Eliquis and Reblozyl. Despite challenges, the company aims for... 
Via Benzinga
News headline image
PLTR Stock: Palantir Beefs Up Healthcare AI Work Through Parexel Deal ↗
Palantir stock is slipping on Thursday even as PLTR traders learn of a new contract between the data company and Parexel. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q1 2024 ↗
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts ↗
Bristol-Myers Squibb layoffs will see the company reduce its headcount by 6% as part of an effort to reduce expenses in 2024. 
Via InvestorPlace
Topics Workforce
News headline image
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript ↗
BMY earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
88 89 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.